A University of Rochester research team is reporting a new way to detect cancer cells with a "liquid biopsy" that's designed to be simpler, faster, and more informational than current methods. What is ...

Researchers have created an imaging agent that will allow scientists and clinicians to visualize a bacterial infection caused by Enterobacterales pathogens while they're happening. These infections ...

CytoMAD (Cyto-Morphology Adversarial Distillation) combines AI and microfluidic technology to do label-free imaging of tumours at the individual cell level. It can capture cell images "at great speed, ...

The company behind an imaging agent meant to identify prostate cancer said it received FDA approval on Thursday for use in patients with suspected metastasis or recurrence. Lantheus Holdings, Inc.

More and more areas of medicine are relying on support from artificial intelligence (AI). This is particularly true for the wide range of questions based on the evaluation of image data: for example, ...

The Food and Drug Administration has approved a new imaging agent to detect prostate cancer after it has spread to other parts of the body, the company that makes the agent said Thursday. Experts say ...

In drug development and clinical trials, attention is paid not only to pharmacokinetic analysis of the drug, but increasingly to characteristics of the tumor, using techniques such as ...

New imaging technology allows scientists to see the widespread loss of brain synapses in early stages of Alzheimer's disease, a finding that one day may help aid in drug development, according to a ...